Challenges and Financial Risks for Healthcare Companies

This chapter discusses the unique challenges that healthcare companies face in bringing innovative treatments to market while minimizing risks and side effects. It also highlights the financially relevant ESG risks and opportunities for Johnson & Johnson (J&J), including allegations and controversies that can impact the company's bottom line.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app